Loading...
XTAI4104
Market cap429mUSD
Dec 26, Last price  
85.90TWD
1D
-0.12%
1Q
-2.61%
Jan 2017
122.65%
Name

Excelsior Medical Co Ltd

Chart & Performance

D1W1MN
XTAI:4104 chart
P/E
18.80
P/S
1.70
EPS
4.57
Div Yield, %
3.85%
Shrs. gr., 5y
2.92%
Rev. gr., 5y
5.35%
Revenues
8.23b
+14.56%
14,300,782,00015,355,606,0005,994,336,0005,998,988,0005,740,961,0005,806,677,0006,202,884,0006,205,758,0006,095,337,0006,345,031,0006,457,362,0006,675,494,0006,573,152,0007,186,828,0008,233,404,000
Net income
747m
+11.86%
311,950,000355,692,000333,970,000275,785,000299,942,000285,681,000379,000,000389,557,000399,047,000451,562,000514,755,000571,670,000607,149,000667,453,000746,605,000
CFO
107m
-83.19%
693,512,000-33,458,000-528,524,000717,257,000357,477,000736,736,000739,959,000449,713,000-487,388,000192,434,0001,194,496,000869,433,000945,049,000637,126,000107,101,000
Dividend
Apr 19, 20243.8 TWD/sh
Earnings
Jun 20, 2025

Profile

Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medical institution, surgical equipment, and medical assistant electronics; and cosmetic equipment. It also provides medical administration services for single department. The company was founded in 1988 and is based in New Taipei City, Taiwan.
URL
https://www.excelsiormedical.com.tw/
IPO date
Jun 08, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
8,233,404
14.56%
7,186,828
9.34%
6,573,152
-1.53%
Cost of revenue
7,537,275
6,566,075
5,969,667
Unusual Expense (Income)
NOPBT
696,129
620,753
603,485
NOPBT Margin
8.45%
8.64%
9.18%
Operating Taxes
221,230
178,399
151,447
Tax Rate
31.78%
28.74%
25.10%
NOPAT
474,899
442,354
452,038
Net income
746,605
11.86%
667,453
9.93%
607,149
6.21%
Dividends
(540,953)
(494,021)
(494,021)
Dividend yield
4.11%
5.15%
6.34%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,204,853
626,401
552,608
Long-term debt
543,624
454,968
491,808
Deferred revenue
12,474
Other long-term liabilities
16,308
17,297
5,308
Net debt
(7,734,578)
(5,961,534)
(5,586,041)
Cash flow
Cash from operating activities
107,101
637,126
945,049
CAPEX
(142,637)
(172,505)
(168,754)
Cash from investing activities
(158,457)
(690,005)
144,125
Cash from financing activities
(104,512)
(633,889)
(593,908)
FCF
(349,702)
288,046
653,315
Balance
Cash
3,406,068
3,228,613
3,771,660
Long term investments
6,076,987
3,814,290
2,858,797
Excess cash
9,071,385
6,683,562
6,301,799
Stockholders' equity
6,999,476
9,182,254
8,536,017
Invested Capital
5,371,473
4,341,060
4,160,210
ROIC
9.78%
10.41%
10.33%
ROCE
5.52%
5.51%
5.67%
EV
Common stock shares outstanding
156,262
156,406
156,494
Price
84.19
37.30%
61.32
23.23%
49.76
2.68%
Market cap
13,155,698
37.17%
9,590,809
23.16%
7,787,159
3.06%
EV
7,721,070
5,726,152
4,208,441
EBITDA
961,805
843,191
806,439
EV/EBITDA
8.03
6.79
5.22
Interest
17,197
10,449
8,761
Interest/NOPBT
2.47%
1.68%
1.45%